Evotec Se Adr Stock Total Asset
| EVO Stock | USD 4.78 0.13 2.65% |
Evotec SE ADR fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Stock. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 2.3 B | 2.4 B | |
| Intangibles To Total Assets | 0.13 | 0.24 |
Evotec | Total Asset |
Evotec SE ADR Company Total Asset Analysis
Evotec SE's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Evotec SE Total Asset | 2.3 B |
Most of Evotec SE's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Evotec Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Evotec SE is extremely important. It helps to project a fair market value of Evotec Stock properly, considering its historical fundamentals such as Total Asset. Since Evotec SE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evotec SE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evotec SE's interrelated accounts and indicators.
Click cells to compare fundamentals
Evotec Total Asset Historical Pattern
Today, most investors in Evotec SE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evotec SE's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Evotec SE total asset as a starting point in their analysis.
Evotec SE Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Evotec Total Assets
Total Assets |
|
Based on the latest financial disclosure, Evotec SE ADR has a Total Asset of 2.3 B. This is 69.43% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The total asset for all United States stocks is 92.2% higher than that of the company.
Evotec Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in total asset category among its peers.
Evotec SE Current Valuation Drivers
We derive many important indicators used in calculating different scores of Evotec SE from analyzing Evotec SE's financial statements. These drivers represent accounts that assess Evotec SE's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Evotec SE's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 2.3B | 3.5B | 1.3B | 1.9B | 2.0B | |
| Enterprise Value | 1.9B | 2.4B | 3.3B | 1.4B | 2.0B | 2.1B |
Evotec SE ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Evotec SE's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Evotec SE's managers, analysts, and investors.Environmental | Governance | Social |
Evotec SE Institutional Holders
Institutional Holdings refers to the ownership stake in Evotec SE that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Evotec SE's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Evotec SE's value.| Shares | Bank Of America Corp | 2023-12-31 | 5.7 K | Fmr Inc | 2023-12-31 | 3 K | Ubs Group Ag | 2023-12-31 | 2.3 K | Quadrant Capital Group Llc | 2023-12-31 | 2.1 K | U.s. Bancorp | 2023-12-31 | 1.2 K | Signaturefd, Llc | 2023-12-31 | 994 | Hhm Wealth Advisors, Llc | 2023-12-31 | 450 | Gamma Investing Llc | 2023-12-31 | 285 | First Manhattan Co. Llc | 2023-12-31 | 225 | Mubadala Investment Company Pjsc | 2023-12-31 | 4.6 M | Federated Hermes Inc | 2023-12-31 | 576.9 K |
Evotec Fundamentals
| Return On Equity | -0.0791 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 987.57 M | ||||
| Shares Outstanding | 354.37 M | ||||
| Shares Owned By Institutions | 1.41 % | ||||
| Number Of Shares Shorted | 143.67 K | ||||
| Price To Earning | 444.00 X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 3.17 X | ||||
| Revenue | 781.43 M | ||||
| Gross Profit | 151.54 M | ||||
| EBITDA | (7.16 M) | ||||
| Net Income | (83.91 M) | ||||
| Cash And Equivalents | 823.67 M | ||||
| Cash Per Share | 2.33 X | ||||
| Total Debt | 626.2 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 6.25 X | ||||
| Cash Flow From Operations | 33.95 M | ||||
| Short Ratio | 0.58 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 11.64 | ||||
| Number Of Employees | 5.05 K | ||||
| Beta | 1.16 | ||||
| Market Capitalization | 1.74 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | (476.29 M) | ||||
| Working Capital | 438.59 M | ||||
| Five Year Return | 4.88 % | ||||
| Net Asset | 2.3 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Evotec Stock
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:Check out Evotec SE Piotroski F Score and Evotec SE Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 2.194 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0003 | Return On Equity (0.08) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.